Product Overview
Structure
1 tablet contains:
active substance:
bromhexine hydrochloride - 0.008 g
excipients:
sucrose (sugar) - 0.081 g
potato starch - 0.010 g
calcium stearate - 0.001 g
pharmachologic effect
Mucolytic (secretolytic) drug, has an expectorant and weak antitussive effect. Reduces sputum viscosity (depolymerizes mucoprotein and mucopolysaccharide fibers, increases the serous component of bronchial secretion); activates ciliated epithelium, increases volume and improves sputum discharge. It stimulates the production of endogenous surfactant, which ensures the stability of alveolar cells during respiration.
Indications
Respiratory tract diseases accompanied by difficulty in viscous sputum discharge: tracheobronchitis, bronchitis of various etiologies (including those complicated by bronchiectasis), bronchial asthma, pulmonary tuberculosis, pneumonia (acute and chronic), cystic fibrosis.
Remediation of the bronchial tree in the preoperative period and during medical and diagnostic intrabronchial manipulations, prevention of accumulation of thick viscous sputum in the bronchi after surgery.
Contraindications
Hypersensitivity, peptic ulcer, pregnancy (I trimester); lactation period; children's age (up to 6 years).
Carefully:
Renal and / or liver failure; diseases of the bronchi, accompanied by excessive accumulation of secretions, a history of gastric bleeding.
Side effects
Interaction
How to take, course of administration and dosage
The therapeutic effect may occur on the 4th-6th day of treatment.
Patients with renal failure are prescribed lower doses or increase the interval between administrations.
Special instructions
During treatment, it is necessary to take a sufficient amount of fluid, which increases the expectorant effect of bromhexine.
In children, treatment should be combined with postural drainage or vibration massage of the chest, facilitating the removal of secretions from the bronchi
Release form
Tablets